AbbVie’s “patent thicket” strategy and aggressive drug pricing tactics have made it a prominent example of pharma finagling. But the company isn’t the only beneficiary.

It was an unexpected message: invest in Israeli health technology today in order to reap the benefits tomorrow of innovations spurred by the Israel-Gaza conflict.

A lawsuit spurred by a series of STAT stories accuses UnitedHealth of deploying an algorithm with a known high error rate, as investigative journalism flourishes.

It’s open enrollment season for Medicare, but star ratings for Medicare Advantage plans, meant to promote consumerism and value, can contain misleading information.

Grappling with what ChatGPT and generative AI will mean for health and medicine? The president of the National Academy of Medicine is both “excited” and “scared.”

The patient safety movement has succeeded in getting the president to consider their policy proposals, but if hospitals are hesitant, implementation will be difficulty